Clinical Trial Update: Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours [Phase 1]

View source ↗

Summary

Phase I study of WX-037 alone and in combination with WX-554 in advanced solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• WX-037
• WX-554

Snippet

Sponsor: Heidelberg Pharma AG | Conditions: Advanced Solid Tumours | Phase 1 | Status: TERMINATED